influence of gut microbiota on the progression of Type 2 Diabetes

• Lysandro Pinto Borges,
• Pamela Chaves de Jesus,
• Jessiane Bispo de Souza,
• Deise Maria Rego Rodrigues Silva,
• Pedro Henrique Macedo Moura,
• Ronaldy Santana Santos,
• Marina dos Santos Barreto,
• Adriana Gibara Guimarães,
• Lucas Alves da Mota Santana,
• Otavio Cabral-Marques,
• Eloia Emanuelly Dias Silva

Affiliations

Lysandro Pinto Borges

ORCiD

Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-220, SP, Brazil; Department of Pharmacy, Health and Biological Sciences Center, Federal University of Sergipe, São Cristóvão 49107-230, SE, Brazil

Pamela Chaves de Jesus

ORCiD

Department of Pharmacy, Health and Biological Sciences Center, Federal University of Sergipe, São Cristóvão 49107-230, SE, Brazil

Jessiane Bispo de Souza

ORCiD

Department of Pharmacy, Health and Biological Sciences Center, Federal University of Sergipe, São Cristóvão 49107-230, SE, Brazil

Deise Maria Rego Rodrigues Silva

ORCiD

Department of Pharmacy, Health and Biological Sciences Center, Federal University of Sergipe, São Cristóvão 49107-230, SE, Brazil

Pedro Henrique Macedo Moura

ORCiD

Department of Pharmacy, Health and Biological Sciences Center, Federal University of Sergipe, São Cristóvão 49107-230, SE, Brazil

Ronaldy Santana Santos

ORCiD

Department of Pharmacy, Health and Biological Sciences Center, Federal University of Sergipe, São Cristóvão 49107-230, SE, Brazil

Marina dos Santos Barreto

ORCiD

Department of Pharmacy, Health and Biological Sciences Center, Federal University of Sergipe, São Cristóvão 49107-230, SE, Brazil

Adriana Gibara Guimarães

ORCiD

Department of Pharmacy, Health and Biological Sciences Center, Federal University of Sergipe, São Cristóvão 49107-230, SE, Brazil

Lucas Alves da Mota Santana

ORCiD

Graduate Program in Dentistry, Health and Biological Sciences Center, Federal University of Sergipe, Aracaju 49060-102, SE, Brazil

Otavio Cabral-Marques

ORCiD

Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-220, SP, Brazil; DO'R Institute for Research, São Paulo, Brazil; Department of Medicine, Division of Molecular Medicine, Laboratory of Medical Investigation 29, University of São Paulo (USP) School of Medicine, São Paulo, Brazil; Interunit Postgraduate Program on Bioinformatics, Institute of Mathematics and Statistics (IME), University of Sao Paulo (USP), Sao Paulo, SP, Brazil; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo (USP), São Paulo, SP, Brazil

Eloia Emanuelly Dias Silva

ORCiD

Department of Biological Sciences, Health and Biological Sciences Center, Federal University of Sergipe, São Cristóvão 49107-230, SE, Brazil; Tel: +5579996396324; E-mail: [email protected]